Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ARB vs MERIX overlap: 31% of top holdings shared

Bottom line

How much do ARB and MERIX overlap?

31% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 26.1% of ARB's assets and 34.8% of MERIX's. They share a meaningful core but differ in the rest of the portfolio.

MERIX holds far more positions (563 vs 145), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

ARBMERIX
Weight overlap (top 25)31%
Shared holdings10
Weight in shared holdings26.1%34.8%
Total positions145563
Expense ratio0.76%1.26%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings ARB and MERIX have in common

Holding% of ARB% of MERIXOverlap
Warner Bros Discovery Inc3.59%5.45%3.59%
Electronic Arts Inc2.80%6.19%2.80%
Chart Industries Inc2.72%4.69%2.72%
Penumbra Inc2.71%1.65%1.65%
Webster Financial Corp2.70%4.15%2.70%
Norfolk Southern Corp2.66%5.92%2.66%
UniFirst Corp/MA2.34%2.46%2.34%
DigitalBridge Group Inc2.33%2.07%2.07%
Organon & Co2.29%0.61%0.61%
Qorvo Inc1.93%1.66%1.66%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ARB

  1. Morgan Stanley Prime Broker US — 15.53%
  2. Morgan Stanley & Co. LLC — 2.99%
  3. State Street Global Advisors — 2.99%
  4. Clearwater Analytics Holdings Inc — 2.79%
  5. AES Corp/The — 2.78%
  6. Masimo Corp — 2.78%
  7. Globalstar Inc — 2.49%
  8. National Storage Affiliates Trust — 2.41%
  9. KalVista Pharmaceuticals Inc — 2.35%
  10. Silicon Laboratories Inc — 2.35%
  11. Janus Henderson Group PLC — 2.34%
  12. Beazley PLC — 2.28%
  13. TopBuild Corp — 1.85%
  14. Esperion Therapeutics Inc — 1.84%
  15. Catalyst Pharmaceuticals Inc — 1.84%

Only in MERIX

  1. Goldman Sachs Trust — 7.63%
  2. Endeavor Group Holdings Inc — 5.68%
  3. Goldman Sachs Trust — 4.82%
  4. Virtus Event Opportunities Trust — 4.15%
  5. Arc Resources Ltd — 2.69%
  6. Caesars Entertainment Inc — 1.49%
  7. Roku Inc — 1.45%
  8. Altaba Inc Escrow — 1.33%
  9. Organon & Company — 1.03%
  10. Agriculture & Natural Solutions Acquisition Corp — 0.83%
  11. Echostar Corp — 0.74%
  12. Kenvue Inc — 0.67%
  13. K&f Growth Acquisition Corp II — 0.59%
  14. Boralex Inc — 0.55%
  15. Select Medical Holdings Corp — 0.55%

Asset mix

Asset typeARBMERIX
Stocks77.6%80.1%
Other15.5%—
Cash & short-term funds6.8%12.5%
Bonds—3.0%
Loans—0.2%
FX derivatives—0.1%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryARBMERIX
US81.4%66.7%
KY0.7%25.5%
GB7.1%—
CA5.2%3.3%
JE3.6%0.4%
NL1.7%—
FR0.6%—
VG—0.4%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do ARB and MERIX overlap?
About 31% by weight. 10 securities appear in both funds' top 25 holdings; they make up 26.1% of ARB's assets and 34.8% of MERIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do ARB and MERIX have in common?
The largest shared holdings are Warner Bros Discovery Inc, Electronic Arts Inc, Chart Industries Inc, Webster Financial Corp, Norfolk Southern Corp.
Should I own both ARB and MERIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, ARB or MERIX?
MERIX is broader, with 563 positions versus 145 for ARB. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.